Palbociclib
ATC L01EF01 · 10 markets · 100 records
AU 31 records · 7 strengths
- 125 mgtabletIbranceIBRANCE palbociclib 125 mg capsule blister pack、PALANCE Palbociclib 100 mg tablet blister pack、PALBOCICLIB RBX Palbociclib 100 mg tablet blister pack、PALBOCICLIB SUN Palbociclib 100 mg tablet blister pack
- 100 mgtabletIbranceIBRANCE palbociclib 125 mg capsule blister pack、PALANCE Palbociclib 100 mg tablet blister pack、PALBOCICLIB RBX Palbociclib 100 mg tablet blister pack、PALBOCICLIB SUN Palbociclib 100 mg tablet blister pack
- 75 mgtabletIbranceIBRANCE palbociclib 125 mg capsule blister pack、PALANCE Palbociclib 100 mg tablet blister pack、PALBOCICLIB RBX Palbociclib 100 mg tablet blister pack、PALBOCICLIB SUN Palbociclib 100 mg tablet blister pack
- 125 mgcapsuleCIP PALBOCICLIB palbociclib 75 mg capsule bottleCIPALON palbociclib 75 mg capsule bottle、CIPLA PALBOCICLIB palbociclib 75 mg capsule bottle、IBRANCE palbociclib 125 mg capsule blister pack、IBRANCE palbociclib 125 mg capsule bottle
- 100 mgcapsuleCIP PALBOCICLIB palbociclib 75 mg capsule bottleCIPALON palbociclib 75 mg capsule bottle、CIPLA PALBOCICLIB palbociclib 75 mg capsule bottle、IBRANCE palbociclib 125 mg capsule blister pack、IBRANCE palbociclib 125 mg capsule bottle
- 75 mgcapsuleCIP PALBOCICLIB palbociclib 75 mg capsule bottleCIPALON palbociclib 75 mg capsule bottle、CIPLA PALBOCICLIB palbociclib 75 mg capsule bottle、IBRANCE palbociclib 125 mg capsule blister pack、IBRANCE palbociclib 125 mg capsule bottle
Records without a stated strength · 1 Ibrance
CA 12 records · 3 strengths
US 9 records · 6 strengths
GB 9 records · 6 strengths
MX 7 records · 2 strengths
Records without a stated strength · 2 APELSIN POSITIV、CICLIPAL、CIDAKOG、IBRUROL、INTIARO、PALFIRST IBRANCE-21
SG 6 records · 6 strengths
- 125 mgtabletIbrance
- 100 mgtabletIbrance
- 75 mgtabletIbrance
- 125 mgcapsulePALBONAT CAPSULES 100MG
- 100 mgcapsulePALBONAT CAPSULES 100MG
- 75 mgcapsulePALBONAT CAPSULES 100MG
TW 6 records · 6 strengths
ES 3 records · 3 strengths
HK 3 records · 1 strengths
Records without a stated strength · 1 Ibrance
EU 2 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Ibrance、Palbociclib Viatris
| Strength / form / release | US | GB | CA | AU | SG | ES | MX | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|---|
| 125 mg tablet | Ibrance | Ibrance | Ibrance NAT-PALBOCICLIB PMS-PALBOCICLIB | Ibrance IBRANCE palbociclib 125 mg capsule blister pack PALANCE Palbociclib 100 mg tablet blister pack+2PALBOCICLIB RBX Palbociclib 100 mg tablet blister pack PALBOCICLIB SUN Palbociclib 100 mg tablet blister pack | Ibrance | Ibrance 愛乳適膜衣錠125毫克 | ||||
| 100 mg tablet | Ibrance | Ibrance | Ibrance NAT-PALBOCICLIB PMS-PALBOCICLIB | Ibrance IBRANCE palbociclib 125 mg capsule blister pack PALANCE Palbociclib 100 mg tablet blister pack+2PALBOCICLIB RBX Palbociclib 100 mg tablet blister pack PALBOCICLIB SUN Palbociclib 100 mg tablet blister pack | Ibrance | Ibrance 愛乳適膜衣錠100毫克 | ||||
| 75 mg tablet | Ibrance | Ibrance | Ibrance NAT-PALBOCICLIB PMS-PALBOCICLIB | Ibrance IBRANCE palbociclib 125 mg capsule blister pack PALANCE Palbociclib 100 mg tablet blister pack+2PALBOCICLIB RBX Palbociclib 100 mg tablet blister pack PALBOCICLIB SUN Palbociclib 100 mg tablet blister pack | Ibrance | Ibrance 愛乳適膜衣錠75毫克 | ||||
| 125 mg capsule | Ibrance | Ibrance | CIP PALBOCICLIB palbociclib 75 mg capsule bottle CIPALON palbociclib 75 mg capsule bottle CIPLA PALBOCICLIB palbociclib 75 mg capsule bottle+2IBRANCE palbociclib 125 mg capsule blister pack IBRANCE palbociclib 125 mg capsule bottle | PALBONAT CAPSULES 100MG | Ibrance | Ibrance 愛乳適 膠囊125毫克 | ||||
| 100 mg capsule | Ibrance | Ibrance | CIP PALBOCICLIB palbociclib 75 mg capsule bottle CIPALON palbociclib 75 mg capsule bottle CIPLA PALBOCICLIB palbociclib 75 mg capsule bottle+2IBRANCE palbociclib 125 mg capsule blister pack IBRANCE palbociclib 125 mg capsule bottle | PALBONAT CAPSULES 100MG | Ibrance | Ibrance 愛乳適 膠囊100毫克 | ||||
| 75 mg capsule | Ibrance | Ibrance | CIP PALBOCICLIB palbociclib 75 mg capsule bottle CIPALON palbociclib 75 mg capsule bottle CIPLA PALBOCICLIB palbociclib 75 mg capsule bottle+2IBRANCE palbociclib 125 mg capsule blister pack IBRANCE palbociclib 125 mg capsule bottle | PALBONAT CAPSULES 100MG | Ibrance | Ibrance 愛乳適 膠囊75毫克 | ||||
capsule | APELSIN POSITIV CICLIPAL CIDAKOG | |||||||||
unknown | Ibrance | Ibrance | Ibrance Palbociclib Viatris | |||||||
tablet | IBRANCE-21 |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in MX and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en MX que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 MX 有记录（未在本表显示）。 另有 2 個規格/劑型僅在 MX 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.